| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $26.5M | — | -14.2% |
| SG&A Expense | $16.4M | — | -12.3% |
| Operating Income | -$42.9M | — | +13.5% |
| Interest Expense | $1.5M | — | +66.7% |
| Pre-tax Income | $91.2M | — | +620.8% |
| Income Tax | -$11K | — | -103.1% |
| Net Income | $91.2M | — | +610.5% |
| EPS (Basic) | $0.71 | — | +455.0% |
| EPS (Diluted) | -$0.30 | — | -25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $466.0M | +211.5% | +79.2% |
| Current Assets | $510.9M | +166.8% | +67.2% |
| Total Assets | $531.7M | +152.8% | +66.6% |
| Current Liabilities | $153.8M | -37.9% | +412.7% |
| Long-term Debt | $50.5M | +59.6% | +65.3% |
| Total Liabilities | $205.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$47.9M | — | -5.0% |
| Financing Cash Flow | $362.5M | — | +158.2% |
| +65.8% |
| Stockholders' Equity | $326.7M | +718.2% | +67.1% |